“Lipid Hybrid Nanoparticles in Cancer Therapy: A Promising Nanotechnology-Based Drug Delivery System”, Int. J. Pharm. Sci. Drug Res., vol. 17, no. 4, pp. 371–387, Jul. 2025, doi: 10.25004/IJPSDR.2025.170408.